high prevalence of hypoparathyroidism in patients with beta-thalassemia major
Authors
abstract
introduction: hypoparathyroidism (hpt) is an irreversible but preventable disorder caused by an iron overload which can be considered a typical complication in patients with beta-thalassemia major. patients and method: parathyroid function was evaluated in 130 patients in qom, iran, who suffered from beta-thalassemia major. their serum ferritin levels were checked for monitoring of chelation therapy effects. results: the prevalence of hpt was 14.6% (19/130). the median age of patients with hpt was significantly higher than of patients without hpt (18 vs. 15 years; p=0.03). serum ferritin levels was not significantly different between the two groups (median: 2709 vs. 1512; p=0.95). the prevalence of cardiac diastolic dysfunction in patients with hpt was significantly higher than in normal thalassemic patients (3.1% vs. 15.8%, p=0.04). patients with hypoparathyroidism demonstrated abnormal glucose metabolism (0% vs. 15.8%; p=0.003). conclusion: the high prevalence of hypoparathyroidism demonstrated poor chelation therapy in these patients. close monitoring of ferritin level was recommended. also, the measurement of parathyroid hormone on a regular basis for all thalassemic patients was recommended.
similar resources
Hypoparathyroidism in adult patients with Beta-thalassemia major.
OBJECTIVE To evaluate the prevalence of hypoparathyroidism in adult transfusion-dependent patients with beta-thalassemia major in a teaching referral hospital in Oman. METHODS All adult (>13 years) patients with beta-thalassemia major seen at Royal Hospital in Oman between 2004 and 2006 were studied. Demographic, pharmaceutical, clinical and biochemical data were collected for all the subject...
full textPrevalence of HCVAb and HBsAg in Patients with Beta-thalassemia Major in Amirkola Thalassemia Center
Background and purpose: Beta-thalassemia major is a genetic disorder with known globin defect that leads to chronic hemolytic anemia. Due to the need for recurrent blood transfusion, the risk of infectious diseases such as hepatitis is higher in these patients. Materials and methods: This cross-sectional study recruited 518 patients with thalassemia major in Amirkola Thalassemia Center, 2013-2...
full textCytokine Gene Polymorphisms in Iranian Patients with Beta-Thalassemia Major
Background: β-thalassemia as a hereditary disease is defined as defective synthesis of β-globin chains, resulting in erythropoiesis abnormalities and severe anemia. Different studies have shown that cytokines and cytokine gene polymorphisms play a major role in the pathogenesis of β-thalassemia. Single nucleotide polymorphisms (SNPs) within the promoter region or other regulatory sequences ...
full textEndocrine Disorders in Beta thalassemia Major Patients
Background Thalassemia is the most common hereditary disorder worldwide. The patient's’ survival is dependent on lifetime blood transfusion which leads to iron overload and its toxicity on various organs including endocrine glands. The study aimed to investigate endocrine disorders in patients with Beta-thalassemia major in the Southern Khorasan province, Iran. Materials and Methods In this des...
full textHematuria in patients with Beta-thalassemia major.
INTRODUCTION Our information about renal involvement in beta-thalassemia major is limited. Recently, few studies have reported proteinuria, hypercalcuria, phosphaturia, and oversecretion of tubular damage markers; however, hematuria has not yet been meticulously studied in these patients. We investigated hematuria in patients with beta-thalassemia major. MATERIALS AND METHODS Urinalysis was p...
full textFrequency of Celiac Disease in Children with Beta Thalassemia major
Background We aimed to investigate the frequency of celiac disease in children with β-thalassemia major (B-TM) in Shiraz, southern Iran. Materials and Methods In this study, the prevalence of celiac disease in children with B-TM was evaluated. Children with BTM were screened for celiac disease by ant-tissue transglutaminase (anti-tTG) IgA antibody, IgA level and anti-tTG IgG. A total o...
full textMy Resources
Save resource for easier access later
Journal title:
international journal of hematology-oncology and stem cell researchجلد ۳، شماره ۳، صفحات ۱۷-۲۰
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023